Forty Seven, Inc.

Forty Seven, Inc.

Forty Seven, Inc.

Overview
Date Founded

2014

Headquarters

1490 O'Brien Drive,Suite A,Menlo Park, CA 94025

Type of Company

Public

Employees (Worldwide)

51 - 100

Industries

Pharmaceuticals
Hospitals & Patient Services
Medical Support Services
Biotechnology

Company Description

Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA.

Contact Data
Trying to get in touch with decision makers at Forty Seven, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-Founder

President, Treasurer & Director

Chief Business Officer

Chief Medical Officer

Chief Patent Counsel

Senior Vice President Planning & Operations

Founder & Vice President Research & Early Development

Vice President, Regulatory Affairs & Quality Assurance

Vice President Development Operations

Founder

Board of Directors

Executive Vice President, Corporate Affairs & General Counsel at Gilead Sciences, Inc.

Executive Vice President & Chief Financial Officer at Gilead Sciences, Inc.

Director at Forty Seven, Inc.

Paths to Forty Seven, Inc.
Potential Connections via
Relationship Science
You
Forty Seven, Inc.
Recent Transactions
Details Hidden

Gilead Sciences, Inc. purchases Forty Seven, Inc.

Details Hidden

Forty Seven, Inc. issued USD Common Stock

Details Hidden

Forty Seven, Inc. issued USD Common Stock

Transaction Advisors
Escrow Agent

Advised onForty Seven, Inc. issued USD Common Stock

Legal Advisor

Advised onGilead Sciences, Inc. purchases Forty Seven, Inc.

Underwriter

Advised onForty Seven, Inc. issued USD Common Stock

Managing Director

Advised onForty Seven, Inc. issued USD Common Stock

Legal Advisor

Advised onGilead Sciences, Inc. purchases Forty Seven, Inc.

Legal Advisor

Advised onGilead Sciences, Inc. purchases Forty Seven, Inc.

Advisors & Consultants
Legal Advisor

Partner, Palo Alto at Cooley LLP

Legal Advisor

Partner, Palo Alto at Cooley LLP

Advisor

Partner at Centerview Partners LLC

Clients

Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan.

Key Stats and Financials As of
Market Capitalization
$4.6B
Total Enterprise Value
Earnings Per Share
Investors
Details Hidden

Wellington Management Co. LLP (Private Equity) focuses in companies located in US. The firm invests in consumer discretionary, technology, financial services, biotech, and health care. They provide capital for growth and later stage capital requirement.

Details Hidden

Founder & Vice President Research & Early Development at Forty Seven, Inc.

Details Hidden

Associate Professor at Stanford University

Suppliers
Stanford University Biotechnology | Redwood City, usa

Stanford University, located between San Francisco and San Jose in the heart of California's Silicon Valley, is one of the world's leading teaching and research universities. Since its opening in 1891, Stanford has been dedicated to finding solutions to big challenges and to preparing students for leadership in a complex world.

Lonza Group AG Pharmaceuticals | Basel, Che

Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Pharma & Biotech; Specialty Ingredients; and Corporate. The Pharma & Biotech segment comprises development and manufacture of customized active pharmaceutical ingredients and biopharmaceuticals as well as formulation services and delivery systems. The Specialty Ingredients segment consists of two divisions, consumer health and consumer resources and protection. The Corporate segment includes corporate functions, such as finance and accounting, legal, communication, information technology, and human resources. The company was founded in 1897 and is headquartered in Basel, Switzerland.

Biotechpharma UAB Pharmaceuticals

Biotechpharma UAB is a private company headquartered in Lithuania that operates contract development and manufacturing organization (CDMO) for biopharmaceuticals.

Competitors
Stanford University Investment Services & Portfolio Management - Redwood City, usa

Stanford University, located between San Francisco and San Jose in the heart of California's Silicon Valley, is one of the world's leading teaching and research universities. Since its opening in 1891, Stanford has been dedicated to finding solutions to big challenges and to preparing students for leadership in a complex world.

Amgen, Inc. Biotechnology - Thousand Oaks, CA

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Bristol-Myers Squibb Company Pharmaceuticals - New York, New York

Bristol-Myers Squibb Company Our company has a strong legacy of innovation that began in New York in 1858 when Edward R. Squibb, M.D., founded a pharmaceutical company in Brooklyn, and in 1887 when two friends, William McLaren Bristol and John Ripley Myers purchased a struggling drug manufacturing firm in Clinton. Together, they laid the foundation for our company today — a global BioPharma leader that continues this legacy of innovation.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Forty Seven, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Forty Seven, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Forty Seven, Inc..